Mycophenolic acid antagonizes the activation of cultured human mesangial cells
- 1 September 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (3) , 857-867
- https://doi.org/10.1046/j.1523-1755.2002.00514.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposureKidney International, 2001
- Role of immunocompetent cells in nonimmune renal diseasesKidney International, 2001
- Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbitAtherosclerosis, 2000
- Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidneyKidney International, 2000
- Treatment with Mycophenolate Mofetil Attenuates the Development of Heymann NephritisNephron Experimental Nephrology, 2000
- Role of intron 1 in smooth muscle α-actin transcriptional regulation in activated mesangial cells in vivoKidney International, 1999
- Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in ratsKidney International, 1999
- Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletionNephrology Dialysis Transplantation, 1999
- Regulation of smooth muscle α-actin expression and hypertrophy in cultured mesangial cellsKidney International, 1998
- Differentiation of smooth muscle phenotypes in mouse mesangial cellsKidney International, 1996